TCT 931: Results of a novel percutaneous mechanical arterial thrombectomy device in lower extremity ischemia: sex-specific analysis

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Medtronic; Amgen; Penumbra; Surmodics</li><li>Grant Support/Research Contract - Abbott; Biotronik</li></ul>